LivingGLP1
Study S002060

GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial

Registration

Registration
NCT07613437
Acronym
GLICH
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE2
Masking
NONE
Status
NOT_YET_RECRUITING
Enrollment
200
Start
2026-06-15
Primary completion
2028-06-14
Lead sponsor
Chinese University of Hong Kong
Conditions
Intracerebral Hemorrhage
Interventions
DRUG:Semaglutide, 0.5 mg/mL
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Edema extension distance on Day 7 [Day 7]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.